Injective
INJ
Fundamental comparison between Injective and Zilliqa
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Injective
Zilliqa
Detailed Comparison
| Metric | Injective | Zilliqa |
|---|---|---|
| Price | $4.90 | $0.002535 |
| Market Cap | $489.86M | $49.47M |
| 24h Volume | 61.8M | 7.9M |
| Rank | #— | #— |
| Circulating Supply | 100M | 19.5B |
| ATH | $52.62 | $0.255376 |
Injective vs Zilliqa — Analysis
Injective and Zilliqa are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.
Value Score Comparison
Both coins share an identical Value Score of 70.7, meaning our algorithm rates them equally — "undervalued".
Market Cap & Risk
Injective has a 10x larger market capitalization than Zilliqa. A larger market cap typically means less volatility but also less growth potential. Zilliqa may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, Injective moved 4.00%, while Zilliqa changed 3.00%. Looking at the 7-day window, Injective is at -9.10% and Zilliqa at 4.40%.
Distance from All-Time High
Injective currently trades at 9% of its all-time high ($52.62), while Zilliqa sits at 1% of its ATH ($0.255376). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Both coins are currently equally valued. Monitor the score trends over the coming days to identify a divergence.
